(Q36429488)

14 August 2017

1 reference

title

Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility (English)

1 reference

14 August 2017

1 reference

1 reference

Sarki A Abdulkadir

1

1 reference

14 August 2017

Jongchan Kim

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

14 August 2017

1 reference

14 August 2017

volume

1

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

351-360

1 reference

Prostate-specific and androgen-dependent expression of a novel homeobox gene.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Roles for Nkx3.1 in prostate development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Mutation of the androgen receptor causes oncogenic transformation of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

MYC oncogenes and human neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Modeling prostate cancer in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Cyclin-dependent kinases and pRb: regulators of the proliferation-differentiation switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Retinoblastoma gene mutations in primary human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Fibroblast growth factor 17 is over-expressed in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Role of fibroblast growth factor receptor signaling in prostate cancer cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Genetically defined mouse models that mimic natural aspects of human prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Effect of prolactin on the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Effects of pituitary hormones on the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

A role for estrogen receptor beta in the regulation of growth of the ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Hepsin promotes prostate cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Pten dose dictates cancer progression in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Restriction of neuroblastoma to the prostate gland in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Pten is essential for embryonic development and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

The emerging role of CTLA-4 as an immune attenuator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Antioxidants block prostate cancer in lady transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Transcription-targeted gene therapy for androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.3.351

21 January 2018

Identifiers

DOI

10.1517/14796694.1.3.351

1 reference

14 August 2017

1 reference